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Abstract 
Immunological factors have been involved in the pathogenesis of dilated 
cardiomyopathy (DCM).  The cytotoxic action of macrophages is one of the main 
factors causing cardiac myocyte damage.  Monocyte chemoattractant protein–1 
(MCP-1) is a major signal for the accumulation of monocytes/macrophages.  We 
examined whether MCP-1 was expressed in the myocardium of DCM patients and 
whether the expression level was correlated with the degree of impairment of cardiac 
function.  The expression of MCP-1 in the myocardium was determined by 
immunohistochemistry in endomyocardial biopsy samples from 13 patients.  The 
expression of MCP-1 was found in all myocardial samples from DCM patients but not 
in those from control subjects.  Positive staining for MCP-1 was distinct in cardiac 
myocytes, interstitium and infiltrating cells.  Semi-quantitative analysis revealed that 
the expression of MCP-1 was inversely correlated with left ventricular ejection fraction. 
In conclusions, the expression level of MCP-1 in the myocardium was correlated with 
the degree of impairment of cardiac function in patients with DCM. 
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1. Introduction 
    Immunological factors have been involved in the pathogenesis of dilated 
cardiomyopathy (DCM).  In particular, the cytotoxic action of mononuclear cells is 
thought to be an important factor causing cardiac myocyte damage.  Infiltration of 
mononuclear cells such as macrophages has been demonstrated in the hearts of patients 
with DCM [1].  Macrophages release various proinflammatory cytokines and generate 
reactive oxygen species, which have various effects such as causing cardiac myocyte 
injury, hypertrophy and apoptosis [2].       
    Monocyte chemoattractant protein–1 (MCP-1) is a major signal for the 
accumulation of monocytes/macrophages in several diseases [3].  Aukrust et al. 
reported that circulating levels of MCP-1 were increased in patients with congestive 
heart failure and that the levels were inversely correlated with left ventricular ejection 
fraction (LVEF) [3].  However, the expression of MCP-1 in failing hearts remains 
uncertain.  Therefore, we examined whether MCP-1 was expressed in the myocardium 
of DCM patients and whether the expression level was correlated with the degree of 
impairment of cardiac function. 
 
2. Methods 
2.1. Subjects   
    The patient population studied comprised 20 consecutive patients (13 men and 7 
women; mean age 54 ± 11 years) admitted to Okayama (Japan) University Hospital 
between 1998 and 2000. 
2.2. MCP-1 assay 
    Serum levels of MCP-1 were measured using a human MCP-1 ELISA system 
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(Amersham Pharmacia Biotech, UK).  Immunoenzymatic staining in endomyocardial 
biopsy samples obtained from 13 patients with DCM was performed using a DAKO 
LSAB System (Dako).  Mouse monoclonal anti-human MCP-1 antibody (1:1000 
dilution, American Research Products, Inc.) or anti-human CD68 antibody (1:100 
dilution, DAKO) was added.   The intensity of the immunostaining of MCP-1 was 
graded semiquantitatively on a four-point scale from 0 to 3 in randomly selected 5 
separate high-power fields (x200) from 3 or 4 sections per patient.  Grade 0 indicated 
no staining; grade 1, positive immunostaining in < 25% of the cells; grade 2, positivity 
of 25% to 50% of the cells; and grade 3, positivity of >50% of the cells.  
 
3. Results 
    The serum levels of MCP-1 in 20 patients with DCM were significantly elevated 
compared with those in healthy 33 control subjects (226 ± 54 versus 176 ± 32 pg/mL, 
p<0.0001).  Expression of MCP-1 was found in all myocardial biopsy samples from 
DCM patients but not in those from control subjects.  Positive immunohistochemical 
staining for MCP-1 was distinct in cardiac myocytes (Fig. 1B), interstitium and 
infiltrating cells (Fig. 1C).  Semi-quantitative analysis revealed that the expression of 
MCP-1 in the myocardium was inversely correlated with LVEF (r =-0.669, p<0.05) 
(Fig. 2).  To determine the chemotactic effect of MCP-1 in the myocardium, we 
calculated the numbers of macrophages that were positively stained with anti-human 
CD68 antibody in the endomyocardial biopsy samples.  The mean number of 
macrophages in the myocardial biopsy samples from DCM patients was 12-fold higher 
than that in samples from control subjects (1.2 ± 2.1 versus 0.1 ± 0.3/mm2, p<0.05). 
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4. Discussion 
    The major new finding of this work is that MCP-1 was expressed in the 
myocardium of DCM patients and that the expression level was inversely correlated 
with LVEF.  
    Seino et al. reported the detection of MCP-1 mRNA expression in human 
endomyocardial biopsy specimens from DCM patients by polymerase chain reaction 
analysis [4].  The present study is the first to demonstrate expression of MCP-1 protein 
in the cardiac interstitium and myocytes of DCM patients.  Furthermore, the number 
of infiltrating macrophages was increased in the myocardium of DCM patients.  
MCP-1 may be an important factor in the pathogenesis of DCM. 
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FIGURE LEGENDS 
 
Figure 1.  Immunohistochemical examination of MCP-1 in myocardial biopsy samples.  
A, Immunohistochemical staining in a myocardial biopsy sample from a control subject.  
B, Positive immunohistochemical staining (brown) in a myocardial biopsy sample from 
a DCM patient.  Bar = 100 µm.  C, Positive staining (brown) in the interstitium and 
infiltrating cells.  Bar = 50 µm.  D and E, Negative immunohistochemical staining 
incubated without a primary antibody in a myocardial biopsy sample from a DCM 
patient. 
 
Figure 2.  Correlation between LVEF and the expression levels of MCP-1 in 
myocardial biopsy samples from 13 DCM patients. 
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